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Abstract
Objective: To assess the validity of CRB-65 (Confusion, Respiratory rate.30 breaths/min, BP,90/60 mmHg, age.65 years)
as a pneumonia severity index in a Malawian hospital population, and determine whether an alternative score has greater
accuracy in this setting.
Design: Forty three variables were prospectively recorded during the first 48 hours of admission in all patients admitted to
Queen Elizabeth Central Hospital, Malawi, for management of lower respiratory tract infection over a two month period
(N = 240). Calculation of sensitivity and specificity for CRB-65 in predicting mortality was followed by multivariate modeling
to create a score with superior performance in this population.
Results: Median age 37, HIV prevalence 79.9%, overall mortality 18.3%. CRB-65 predicted mortality poorly, indicated by the
area under the ROC curve of 0.649. Independent predictors of death were: Male sex, ‘‘S’’ (AOR 2.6); Wasting, ‘‘W’’ (AOR 6.6);
non-ambulatory, ‘‘A’’ (AOR 2.5); Temp .38uC or ,35uC, ‘‘T’’ (AOR 3.2); BP,100/60, ‘‘Bp’’ (AOR 3.7). Combining these factors
to form a severity index (SWAT-Bp) predicted mortality with high sensitivity and specificity (AUC: 0.867). Mortality for scores
0–5 was 0%, 3.3%, 7.4%, 29.2%, 61.5% and 87.5% respectively. A score $3 was 84% sensitive and 77% specific for mortality
prediction, with a negative predictive value of 95.8%.
Conclusion: CRB-65 performs poorly in this population. The SWAT-Bp score can accurately stratify patients; #2 indicates
non-severe infection (mortality 4.4%) and $3 severe illness (mortality 45%).
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Introduction
Lower respiratory tract infection (LRTI) is the third greatest
cause of death globally, with 3.16 million deaths worldwide in
2008; half of these occurred in lower or middle income countries
[1]. Amongst patients diagnosed with community acquired
pneumonia (CAP) in sub-Saharan Africa, mortality rates of up
to 23% have been reported [2–3]. Bacterial pneumonia in human
immunodeficiency virus (HIV) positive patients is a World Health
Organisation (WHO) stage 3 diagnosis, and is both a common
index presentation and cause of death [3].
It has been recognised that clinical evaluation of patients with
suspected CAP is prone to error in stratifying mortality risk [4]. To
address this, two major clinical scoring systems were derived. The
CURB-65 score considers five clinical variables (presence or
absence of confusion, serum urea .7 mmol/l, respiratory rate
.30 breaths/minute, blood pressure (BP) ,90 mmHg systolic or
,60 mmHg diastolic and age .65 years) and has become widely
used in the UK [5]; CRB-65, a simplified version not requiring
access to a laboratory, has similar validity, particularly in settings
where expected overall mortality is low [6–7]. The Pneumonia
Severity Index (PSI), most widely used in the USA, is a more
complex scale relying on collation of 20 clinical, laboratory and
radiologic variables [8]. A systematic review and meta-analysis by
Loke and colleagues included 23 high quality validation studies of
these scales, encompassing more than 22 thousand patients. Most
were performed in well-resourced settings, and overall mortality
was 7.6%. They concluded that PSI was the most sensitive test to
exclude low risk patients, but required abundant resources and
good infrastructure; CURB-65, or the simplified CRB-65 were
also found to be robust clinical scales [9]. Chalmers and colleagues
reported similar findings from a meta-analysis conducted accord-
ing to the epidemiologically-focused MOOSE guidelines, but
noted that ‘if the population of patients to which the score is being
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applied is significantly different from the original derivation it may
be necessary to perform local recalibration of the score’ [10].
Importantly, this meta-analysis found the more simple CRB-65 to
be equally accurate in mortality prediction when compared with
PSI and CURB-65 [10]. However, it is notable that few studies
have been conducted in low-resource settings, in environments
where the mortality from CAP is high, or in communities where
HIV rates are high. Furthermore, both CRB-65 and PSI were
derived and validated using the endpoint of 30-day mortality [5,7–
8], whereas it is recognised that a significant proportion of patients
in less developed countries may die within the initial 48 hours of
admission [3].
We therefore aimed to determine the validity of the CRB-65
index in patients presenting to a Malawian hospital with a clinical
diagnosis of CAP, and to identify variables predictive of in-hospital
mortality. A simple assessment tool, based on objective, easily
measurable clinical parameters, was developed, aiming to enable
stratification of patients on initial presentation to hospital and to
guide acute management.
Methods
Study Site and Patient Selection
The study was conducted on the medical admission ward of
Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi.
Malawi is among the ten poorest countries worldwide in terms of
both GDP and per capita income, and has approximately one
doctor per 100 000 population [11]. A significant proportion of
medical care is provided by clinical officers who have completed a
three year training programme and who have limited opportuni-
ties for continued professional development.
All patients presenting with a clinical diagnosis of acute LRTI
over a two month period in February and March 2010 were
eligible. A presumptive diagnosis of CAP was made if; at least two
recognised signs or symptoms of pneumonia were present [12];
with an illness duration of 21 days or less; and LRTI/CAP was the
primary diagnosis recorded by the attending clinician All patients
received empirical antibiotic treatment, based on local microbi-
ological data collected by the Malawi-Liverpool-Wellcome Clin-
ical Research Programme [13–14]. Patients were excluded from
the study if LRTI was not the primary diagnosis; if they had
recently been hospitalized within 14 days presentation; or if the
patient had known malignancy.
Whilst international definitions of CAP require the presence of a
new, presumed infective infiltrate on chest X-ray (CXR) [5], such
confirmation is often not possible in low resource settings due to
infrastructural constraints. Even when available, a delay of 24–
48 hours from admission to performance of CXR means that the
patients at highest risk of early death from LRTI [6,15–16] may
not receive radiological confirmation of diagnosis; additionally, the
inability to perform portable CXR excludes patients who are too
unwell to be transferred to the radiology department. We therefore
chose a pragmatic, clinical case definition to identify a truly
representative sample of patients, aiming to develop a stratification
algorithm ideal for use at initial point of contact.
Data Collection
Clinical data were collected using a proforma (a full list of
variables is available as online Appendix). For repeatedly
measured variables, the most abnormal value reported during
the first 48 hours of admission was recorded.
‘Wasting’ was a nominal (yes/no) variable, and was defined as
an overall assessment of nutritional status by the responsible
clinician, taking into account various factors such as BMI and
MUAC. Many of the patients were too unwell to stand and have
formal BMI calculations undertaken, a challenge that has been
noted in other African studies conducted in the acute setting [17–
18]. To increase objectivity, mid-upper arm circumference
(MUAC) was measured in 30% of cases, with less than 19 cm
being defined as ‘wasting’; among these cases, MUAC strongly
correlated with the potentially more subjective clinical judgement
(Fisher’s exact test; p,0.0001). ‘Confusion’ was defined as
disorientation in time, place or person. Non-ambulatory was
defined as being unable to independently mobilise on admission.
When CXR was available, these were independently interpret-
ed by PW and EB. Where disagreement was noted, a visiting UK
based consultant radiologist was asked to provide a final verdict.
Primary Outcome
The primary outcome was inpatient mortality; longer term
follow-up in the community was beyond the scope of this study.
Statistical Analysis
Sample size was chosen, based on the anticipated 20% inpatient
mortality suggested by previous studies conducted among similar
populations [3,14].
Continuously distributed variables were re-categorised into
binary form using threshold values specified in existing severity
prediction scores and literature pertaining to CAP [4–5,8,16]. A
full list of threshold values applied is detailed in the online
appendix.
The univariate association between each of 43 predictor
variables and in-hospital mortality was analysed using Chi-squared
tests (Table 1). Multivariable logistic regression, using a forward
stepwise method, enabled identification of five independent
associations with mortality (Table 2), which were combined to
produce a new six-point clinical severity score, named SWAT-Bp.
For each patient, a CRB-65 score(0–4) was calculated enabling
comparison of the test characteristics for mortality prediction
between both this existing score and the novel SWAT-Bp score
(Table 3). The area under the receiver operating characteristic
(ROC) curves enabled comparison of the accuracy of both indices.
Data were analysed using SPSS Version 17.0 for Windows.
Ethics statement
Ethical approval was obtained from the College of Medicine
Research Ethics Committee, Malawi and the Department of
Population Sciences Ethics Committee, University of Birmingham,
to collect data from hospital records and pre-collected patient
notes, without individual patient consent. All information was
anonymised at the point of contact with patients’ notes.
Results
Two hundred and forty patients (48.3% male) were enrolled.
Five patients (2%) were lost to follow-up and excluded from
analysis. Median age was 37 (range 16–85, IQR 29–48) years. One
hundred and fifty five were HIV positive (79.9% of those in whom
status was known); 46 patients (19.2% of the cohort) remained of
unknown status at the time of discharge or death. The overall
inpatient mortality was 18.3%; of these deaths, 27% occurred
during the first 48 hours of admission, and 75% during the first
week.
All patients were treated with empirical antimicrobial agents,
based on local microbiological research [13–14]. These included
third generation cephalosporins, most frequently ceftriaxone;
benzylpenicillin in combination with choloramphenicol; and oral
amoxicillin. Choice of antibiotic was not associated with outcome,
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although a trend towards lower mortality was noted amongst
patients who received oral amoxicillin (OR 0.34, p= 0.182); this
most likely reflects clinical judgement that these were low-risk
patients.
Associations with in-hospital mortality
Thirteen variables were found to be significantly associated with
adverse outcome, as detailed in Table 1. Independent associations
with in-hospital mortality were male sex (‘S’); wasting (‘W’); being
non-ambulatory (‘A’), axillary temperature of less than 35uC or
greater than 38uC (‘T’) and blood pressure of less than 100 mmHg
systolic or 60 mmHg diastolic (‘Bp’) (Table 2).
Accuracy of CRB-65 score in predicting mortality
Mortality risk increased with CRB-65 score, rising from 6.3% in
patients with ‘mild’ illness (score of 0), to 42.9% in those classified
as ‘severe’ (scores of 3 or 4) [5]. However, only seven patients were
identified as having severe illness by CRB-65, and a mortality of
21.9% occurred in patients classified as ‘moderate’ (score of 1 or
2); a single adverse feature on CRB-65 was associated with a
mortality risk of 19.7% in our cohort. The sensitivity of a CRB-65
score $2 was 36.4% with a specificity of 80.6% in predicting
mortality; the insensitivity is further demonstrated by a negative
predictive value (NPV) of 84.9% at this level.
Accuracy of SWAT-Bp score in predicting mortality
The relationship between SWAT-Bp score and mortality risk is
shown in Table 3. No patient with a score of 0 died, compared
with an 87.5% mortality amongst patients with a score of 5. A
relatively even spread of patients across the six scores, together
with a stepwise increase in mortality allowed classification into
three risk groups: a score of 0 or 1 carried a mortality risk of 2.2%;
a score of 2 represented intermediate risk with a 7.4% mortality;
and a score of $3 had a mortality of 45.1%, with sensitivity and
specificity of 84.1% and 77% respectively. The high NPV of
95.8% at this level illustrates the accuracy of this score in
identification of patients with mild illness.
Comparison of CRB-65 and SWAT-Bp scoring systems
The ROC curves for CRB-65 (AUC 0.649) and SWAT-Bp
(AUC 0.867) in this study population, and CURB-65 in the
original derivation cohort of Lim and colleagues, illustrate the
differences in accuracy in predicting mortality (Figure 1). The
difference between the AUC for SWAT-Bp and CRB-65 in this
population was highly statistically significant (P,0.001).
Discussion
We present the derivation of a novel score, SWAT-Bp, which
accurately predicts mortality risk in patients presenting to a
Malawian hospital with a clinical presentation of LRTI and a
presumed primary diagnosis of CAP. Patients with a score of 0 or
1 had a mortality risk of 2.2%, and could safely be triaged to
receive outpatient treatment whereas a score of 2 represented
intermediate risk (7.4% mortality) requiring admission for
intravenous antibiotics and fluid therapy. Almost half of the
patients scoring $3 according to SWAT-Bp died in hospital;
identification of these patients at initial point of contact should
allow the rational prioritisation of appropriate bundles of care
aiming at early goal directed therapy [19].
This score identifies the adverse clinical features associated with
mortality risk more accurately than the CRB-65 score which has
been derived and validated amongst large cohorts of patients in
industrialised nations [7,9–10]. Meta-analysis of the existing
predictive scores, CURB-65, CRB-65 and PSI has concluded
with the caveat that these may require re-calibration in
populations with significant differences from previously investigat-
ed cohorts [10,20]. Despite this recommendation, few studies have
Table 1. Univariate association between clinical variables and
mortality.
Clinical feature
N/
total* (%) Died (%) OR p value
Male sex 116 48.3 28 24.1 2.15 0.025
Age.45 78 32.5 6 7.7 0.28 0.004
Age.55 50 20.8 4 8 0.35 0.045
HIV positive 155/194 79.9 32 20.6 1.77 0.266
Confusion 12 5 5 41.7 3.46 0.032
RR.30/min 151 62.9 31 20.5 1.58 0.205
BP,100/60 mmHg 88 36.7 29 33 4.83 ,0.001
BP,90/60 mmHg 57 23.8 21 36.8 4.35 ,0.001
HR.120/min 97 40.4 22 22.7 1.72 0.103
T.386C (axillary) 111 46.3 25 22.5 1.78 0.089
T,356C 19 7.9 9 47.4 4.92 0.001
T.38 or ,356C 134 55.8 34 25.4 3.94 ,0.001
Oxygen saturation
,94%
70/115 60.9 15 21.4 1.85 0.237
Current smoker 26 10.8 8 30.8 2.2 0.083
Wasting 76 31.7 31 40.8 8 ,0.001
Non-Ambulatory 76 31.7 31 40.8 9.33 ,0.001
X-ray performed 147 61.3 18 12.2 0.34 0.002
X-ray: bilateral 54/147 36.7 8 14.8 1.41 0.508
X-ray: multizonal 86/147 58.5 12 14 1.46 0.501
Concurrent TB 35 14.6 9 25.7 1.69 0.222
HAART (in HIV+
patients)+
39/128 30.5 4 10.3 0.39 0.103
CPT (in HIV+ patients)‘ 73/155 47.1 16 21.9 1.39 0.343
CRB-65.1 (‘mod-
severe’)
54 22.5 16 29.6 2.38 0.015
SWATBp score .2
(‘severe’)
82 34.2 37 45.1 17.74 ,0.001
*Unless stated otherwise, N = 240 patients; +Highly Active Anti2Retroviral
Therapy; ^Co-trimoxazole prophylaxis.
doi:10.1371/journal.pone.0082178.t001
Table 2. Clinical variables predictive of mortality in
multivariate analysis.
Variable AOR 95% CI p-value
Male sex (S) 2.64 1.07 – 6.51 0.035
Wasting (W) 6.61 2.61 – 16.7 ,0.001
Non-Ambulatory
(A)
2.46 1.26 – 4.82 0.008
Temp,35 or
.386C (T)
3.18 1.19 – 8.50 0.022
BP,100/60 mmHg
(Bp)
3.72 1.51 – 9.13 0.004
doi:10.1371/journal.pone.0082178.t002
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been conducted in low-resource settings with high HIV seroprev-
alence.
The demographic differences in our population may partly
explain the limitations of CRB-65. Only 10% of patients were
aged over 65; in Malawi, the overall life expectancy is 53 years, a
figure greatly influenced by the national HIV sero-prevalence of
11% [21]. Whilst confusion is a common complication of severe
infections amongst elderly populations [22], it was a rare feature in
our cohort, seen in only 12 (5%) patients. Investigating CAP in
HIV positive Nigerians, a limitation of existing scores was found to
be the skew towards reduced scores in young patients with
relatively few known co-morbidities [23]; similarly, in Italy, PSI
performed poorly in an HIV positive population, tending to
generate low scores in patients who in fact had severe illness and
high risk of death [24]. Studies from industrialised countries have
shown the poor predictive performance of CRB65 and PSI in
young patient cohorts overall [36,37]. By contrast, simple
indicators such as advanced wasting and the inability to walk
unaided, which may be surrogates for advanced HIV infection in a
young population, proved strong predictors of poor outcome in
our study, findings paralleled by studies of adult medical
admissions in Tanzania [17] and tuberculosis patients in Malawi
[18].
In addition to being the first study seeking to identify a
prognostic score among patients presenting with LRTI in this
setting, a major strength of our study is the prospective and
systematic collection of clinical information. The study was
conducted in a real-life setting with several clinicians involved in
patient care; many of the limitations encountered were reflective of
the real-life environment in which we would propose our score to
be used. The variables included in the model have the advantage
of being easily measurable, objective physiological observations,
which minimise risk of subjective bias. Furthermore, implemen-
tation of the score would be possible with minimal training and
Table 3. CRB-65 and SWAT-Bp scores; mortality prediction and test characteristics.
Score No. features N Died (%) No. features Sensitivity (%) Specificity (%) PPV (%) NPV (%)
CRB-65 0 64 4 (6.3) $0 100 - 18.3 2
1 122 24 (19.7) $1 90.1 30.6 22.7 93.8
2 47 13 (27.7) $ 36.4 80.6 29.6 84.9
3 6 2 (33.3) $3 6.8 98 42.9 82.4
4 1 1 (100) 4 2.3 100 100 8
SWAT-Bp 0 29 0 (0) $0 100 - 18.3 -
1 61 2 (3.3) $1 100 14.8 20.9 100
2 68 5 (7.4) $2 95.5 44.9 28 97.8
3 48 14 (29.2) $3 84.1 77 45.1 95.8
4 26 16 (61.5) $4 52.3 94.4 67.6 90.7
5 8 7 (87.5) 5 1 99.5 87.5 86.2
doi:10.1371/journal.pone.0082178.t003
Figure 1. ROC curves for mortality prediction by SWAT-Bp and CRB-65 scores.
doi:10.1371/journal.pone.0082178.g001
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without any major resource implications for an already stretched
healthcare system.
Although there is potential for subjectivity in the variable of
‘wasting’, we have demonstrated very close correlation between
clinicians’ assessments of wasting and the objective measure of
MUAC (see Methods), thus illustrating the reproducibility of this
variable in this setting. Whether this potential subjectivity impacts
upon external validity will need to be investigated during the
implementation stage of SWATBp.
The reliability of recording of physiological observations in this
setting is a potential limitation of this study, in the context of its
retrospective design. Many patients did not have initial variables
recorded on first presentation. Therefore, to maximise the
sensitivity of the scoring system, the most-abnormal value in the
first 48 hours of admission was recorded. Future prospective
studies will ensure variables are collected for all subjects on initial
presentation, to validate the use of SWAT-Bp as an admission
triage score.
It could be argued that the lack of radiological confirmation of
diagnosis in 39% of our cohort undermines the significance of our
findings. However, we sought to establish a pragmatic, clinical
case definition similar to that seen in the emergency departments
of hospitals across sub-Saharan Africa. Focusing our analysis on
those patients who had CXR performed revealed a mortality of
only 12% compared with 18.5% in the cohort as a whole; this
likely reflects the reduced mortality risk in patients who were
considered well enough to be transferred to the X-ray department,
and who had survived for long enough for the investigation to be
performed. Indeed, on univariate analysis, having had a CXR
performed was associated with reduced mortality risk (OR 0.34,
p = 0.002). Whilst we would not dispute the value of CXR in the
diagnosis of CAP, there is increasing evidence that this investiga-
tion has limitations in populations with high rates of HIV. In a
study of 49 HIV positive South Africans with a diagnosis of CAP,
85% of patients had radiological abnormalities on high resolution
computed tomography (HRCT) that were not apparent on plain
CXR [25]. Furthermore, recent consideration of the value of
CXR in tuberculosis in Malawi has drawn attention to limitations
in both technical quality and the interpretative skill of the majority
of clinicians [26].
The difficulty in establishing clinical diagnoses with certainty
has been highlighted in other Malawian studies [18,27]. Even with
significant research infrastructure and access to high quality
microbiology laboratories, in patients presenting with an acute
respiratory illness there will remain a large proportion in whom
the final diagnosis is classified as ‘possible’ or ‘probable’ rather
than ‘proven’ [14,18,27]. Up to a third of patients may have
concurrent infection with more than one organism, and high rates
of bacteraemia and mycobacteraemia have been reported [27].
Recent work has suggested that CURB-65 has utility as a generic
risk score in adult acute medical admissions [28], to be used in a
similar manner to the modified early warning score (MEWS)
which has become integrated into routine management in the UK
[29]. Hence, despite the limitations introduced by the limited
diagnostic resources available to our study cohort, we would argue
that the SWAT-Bp score has great merit in identifying high risk of
death among patients with a clinical presentation which is
consistent with pneumonia.
It is notable that physiological derangements noted in our high
risk patients overlap with the features of Systemic Inflammatory
Response Syndrome (SIRS). Studies conducted in the intensive
care units (ICU) of industrialised nations have demonstrated a
majority of patients who die from CAP to meet the clinical case
definitions for severe sepsis [30], and that prognostic scores
designed for both sepsis and pneumonia each have their merits
and limitations in patients with pneumonia [31]. The initial
management of severe sepsis was streamlined in 2008 by the
Surviving Sepsis Campaign [32]; whilst these guidelines assume
the availability of abundant resources to be delivered on an ICU
setting, there exist valuable principles which can be extrapolated to
the patient group we describe in this paper.
Being aware of the many challenges inherent in clinical
medicine in low-resource settings, the WHO has developed
protocols summarised as the Integrated Management of Adoles-
cent and Adult Illness (IMAI) [33], which are analogous to the
more well established Integrated Management of Childhood
Illness (IMCI) pathways. These seek to enable less well trained
clinicians with few resources to rapidly identify patients at high risk
of poor outcome, to decide which patients require referral to a
higher level of care, and provide guidance regarding the pragmatic
empirical management of major medical conditions including
CAP. Our score, based on a clinical diagnosis of CAP, would be a
valuable addition to these pathways. Furthermore, given the
overlap between LRTI, CAP, SIRS and sepsis, studies evaluating
SWAT-Bp amongst patients presenting with a potential diagnosis
of sepsis, regardless of its aetiology, would be informative.
A positive HIV status was not significantly associated with in-
patient mortality, consistent with findings reported in a local
cohort of TB patients [18]. HIV is without doubt a major risk
factor for the acquisition of opportunistic infections such as CAP
and TB, and the local impact of this is evidenced by 85% HIV
seroprevalence among medical inpatients at QECH, the majority
of whom have presented with an acute infectious illness (Waitt P,
unpublished data). However, once bacterial infection is estab-
lished, the processes of SIRS and sepsis carry high mortality
irrespective of HIV status, as recently reported in Uganda [34].
That 19% of our patients did not have a known HIV diagnosis by
the end of the study was not ideal, given the target for universal
testing. However, this is rarely achievable in the acute setting due
to the need for patient counselling and confidential testing in a
clinical area where confidentiality can be maintained. An analysis
of Nigerian patients diagnosed with CAP over a 5 year period
revealed that only 35% of patients were tested for HIV [35];
similar limitations were acknowledged.
Conclusion
We present a novel six-point prognostic score (SWAT-Bp) for
prediction of mortality risk in patients presenting with a LRTI in a
low-resource, high HIV seroprevalence population such as
Malawi. This tool is ideal for stratifying the appropriate intensity
of management of patients, leading to more effective use of
resources and prioritisation of clinical care. Further validation is
required among cohorts of similar patients, before consideration of
more widespread use of the score.
Supporting Information
Table S1 Full list of variables investigated and thresholds for
abnormality.
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